Login Register Cart 0
Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe Translate in Chinese
Review Article

The Role of High-density Lipoprotein in Oral and Dental Diseases

Author(s): Leila Sadeghalbanaei, Farinaz Shirban, Mohammad Bagherniya*, Thozhukat Sathyapalan and Amirhossein Sahebkar*

Volume 30, Issue 20, 2023

Published on: 21 October, 2022

Page: [2226 - 2246] Pages: 21

DOI: 10.2174/0929867329666220901120654

Price: $65

Abstract

High-density lipoprotein (HDL) is the smallest and densest of the lipoproteins. Beyond its well-known cardiovascular protective function, it has other actions, including structural function, anti-inflammatory, antioxidant, anti-thrombotic effects, transport of bioactive molecules, and induction of signal transduction pathways. Further, there is a mutual connection between oral health and general health. Hence HDL could be a potentially crucial factor relating oral health to general health. As far as we know, no comprehensive study has been carried out to date, which has explored the association between HDL concentration and oral diseases including lichen plan, recurrent aphthous ulcers, candidiasis, implant osseointegration, oral cancer and precancerous conditions. Here in this review, we summarized the relationship between HDL and oral health, suggesting a significant association between HDL concentration and oral health.

Keywords: HDL, oropharyngeal cancer, dental health, oral health, oral disease, dental disease.

« Previous Next »
[1]
Peres, M.A.; Macpherson, L.M.D.; Weyant, R.J.; Daly, B.; Venturelli, R.; Mathur, M.R.; Listl, S.; Celeste, R.K.; Guarnizo-Herreño, C.C.; Kearns, C.; Benzian, H.; Allison, P.; Watt, R.G. Oral diseases: A global public health challenge. Lancet, 2019, 394(10194), 249-260.
[http://dx.doi.org/10.1016/S0140-6736(19)31146-8] [PMID: 31327369]
[2]
Petersen, P.E.; Bourgeois, D.; Ogawa, H.; Estupinan-Day, S.; Ndiaye, C. The global burden of oral diseases and risks to oral health. Bull. World Health Organ., 2005, 83(9), 661-669.
[PMID: 16211157]
[3]
Gupta, N.; Gupta, N.D.; Gupta, A.; Goyal, L.; Garg, S. The influence of type 2 diabetes mellitus on salivary matrix metalloproteinase-8 levels and periodontal parameters: A study in an Indian population. Eur. J. Dent., 2015, 9(3), 319-323.
[http://dx.doi.org/10.4103/1305-7456.163222] [PMID: 26430357]
[4]
Teshome, A.; Yitayeh, A. The effect of periodontal therapy on glycemic control and fasting plasma glucose level in type 2 diabetic patients: Systematic review and meta-analysis. BMC Oral Health, 2016, 17(1), 31.
[http://dx.doi.org/10.1186/s12903-016-0249-1] [PMID: 27473177]
[5]
Nazir, M.A. Prevalence of periodontal disease, its association with systemic diseases and prevention. Int. J. Health Sci., 2017, 11(2), 72-80.
[PMID: 28539867]
[6]
Martinez-Herrera, M.; Silvestre-Rangil, J.; Silvestre, F-J. Association between obesity and periodontal disease. A systematic review of epidemiological studies and controlled clinical trials. Med. Oral Patol. Oral Cir. Bucal, 2017, 22(6), e708-e715.
[http://dx.doi.org/10.4317/medoral.21786] [PMID: 29053651]
[7]
Peng, J.; Song, J.; Han, J.; Chen, Z.; Yin, X.; Zhu, J.; Song, J. The relationship between tooth loss and mortality from all causes, cardio-vascular diseases, and coronary heart disease in the general population: Systematic review and dose-response meta-analysis of prospec-tive cohort studies. Biosci. Rep., 2019, 39(1)BSR20181773
[http://dx.doi.org/10.1042/BSR20181773] [PMID: 30530864]
[8]
Kane, S.F. The effects of oral health on systemic health. Gen. Dent., 2017, 65(6), 30-34.
[PMID: 29099363]
[9]
Tahamtan, S.; Shirban, F.; Bagherniya, M.; Johnston, T.P.; Sahebkar, A. The effects of statins on dental and oral health: A review of preclinical and clinical studies. J. Transl. Med., 2020, 18(1), 155.
[http://dx.doi.org/10.1186/s12967-020-02326-8] [PMID: 32252793]
[10]
Saadeh, R.; Bober-Moken, I.; Challa, S. Relationship between general health behaviors and oral health behaviors in 2015-2016 NHANES adult population. Eur. J. Dent., 2019, 13(3), 405-412.
[http://dx.doi.org/10.1055/s-0039-1698364] [PMID: 31618787]
[11]
Imai, S.; Mansfield, C.J. Oral health in North Carolina: Relationship with general health and behavioral risk factors. N. C. Med. J., 2015, 76(3), 142-147.
[http://dx.doi.org/10.18043/ncm.76.3.142] [PMID: 26510215]
[12]
Navab, M.; Reddy, S.T.; Van Lenten, B.J.; Fogelman, A.M. HDL and cardiovascular disease: Atherogenic and atheroprotective mecha-nisms. Nat. Rev. Cardiol., 2011, 8(4), 222-232.
[http://dx.doi.org/10.1038/nrcardio.2010.222] [PMID: 21304474]
[13]
Rye, K.A. High density lipoprotein structure, function, and metabolism: A new thematic series. The J. Lipid Res., 2013, 54(8), 2031-2033.
[14]
Navab, M.; Yu, R.; Gharavi, N.; Huang, W.; Ezra, N.; Lotfizadeh, A.; Anantharamaiah, G.M.; Alipour, N.; Van Lenten, B.J.; Reddy, S.T.; Marelli, D. High-density lipoprotein: Antioxidant and anti-inflammatory properties. Curr. Atheroscler. Rep., 2007, 9(3), 244-248.
[http://dx.doi.org/10.1007/s11883-007-0026-3] [PMID: 18241620]
[15]
Madsen, C.M.; Varbo, A.; Nordestgaard, B.G. Novel insights from human studies on the role of high-density lipoprotein in mortality and noncardiovascular disease. Arterioscler. Thromb. Vasc. Biol., 2021, 41(1), 128-140.
[PMID: 33232200]
[16]
Bacchetti, T.; Ferretti, G.; Carbone, F.; Ministrini, S.; Montecucco, F.; Jamialahmadi, T.; Sahebkar, A. Dysfunctional high-density lipo-protein: The role of myeloperoxidase and paraoxonase-1. Curr. Med. Chem., 2021, 28(14), 2842-2850.
[http://dx.doi.org/10.2174/0929867327999200716112353] [PMID: 32674726]
[17]
Bahrami, A.; Barreto, G.E.; Lombardi, G.; Pirro, M.; Sahebkar, A. Emerging roles for high-density lipoproteins in neurodegenerative disorders. Biofactors, 2019, 45(5), 725-739.
[http://dx.doi.org/10.1002/biof.1541] [PMID: 31301192]
[18]
Ganjali, S.; Ricciuti, B.; Pirro, M.; Butler, A.E.; Atkin, S.L.; Banach, M.; Sahebkar, A. High-density lipoprotein components and func-tionality in cancer: State of the art. Trends Endocrinol. Metab., 2019, 30(1), 12-24.
[http://dx.doi.org/10.1016/j.tem.2018.10.004] [PMID: 30473465]
[19]
Ganjali, S.; Shirmohammadi, L.; Read, M.I.; Sahebkar, A. High-density lipoprotein functionality in systemic lupus erythematosus. Semin. Arthritis Rheum., 2020, 50(4), 769-775.
[http://dx.doi.org/10.1016/j.semarthrit.2020.05.011] [PMID: 32531506]
[20]
Yazdandoust, S.; Parizadeh, S.M.R.; Ghayour-Mobarhan, M.; Yaghmaei, P.; Sahebkar, A.H. High-density lipoprotein lipid peroxidation as a diagnostics biomarker in coronary artery disease. Biofactors, 2022. biof 1819. [ePub Ahead of Print]
[http://dx.doi.org/10.1002/biof.1819] [PMID: 35080064]
[21]
Sugerman, P.B.; Savage, N.W.; Walsh, L.J.; Zhao, Z.Z.; Zhou, X.J.; Khan, A.; Seymour, G.J.; Bigby, M. The pathogenesis of oral li-chen planus. Crit. Rev. Oral Biol. Med., 2002, 13(4), 350-365.
[http://dx.doi.org/10.1177/154411130201300405] [PMID: 12191961]
[22]
Esteve, E.; Ricart, W.; Fernández-Real, J.M. Dyslipidemia and inflammation: An evolutionary conserved mechanism. Clin. Nutr., 2005, 24(1), 16-31.
[http://dx.doi.org/10.1016/j.clnu.2004.08.004] [PMID: 15681098]
[23]
Toader, M.P.; Taranu, T.; Constantin, M.M.; Olinici, D.; Mocanu, M.; Costan, V.V.; Toader, S. High serum level of interleukin-6 is linked with dyslipidemia in oral lichen planus. Exp. Ther. Med., 2021, 22(3), 987.
[http://dx.doi.org/10.3892/etm.2021.10419] [PMID: 34345269]
[24]
Lai, Y.C.; Yew, Y.W.; Schwartz, R.A. Lichen planus and dyslipidemia: A systematic review and meta-analysis of observational studies. Int. J. Dermatol., 2016, 55(5), e295-e304.
[http://dx.doi.org/10.1111/ijd.13234] [PMID: 26873870]
[25]
Baykal, L. AArıca, D.A.; Yaylı, S.; Örem, A.; Bahadır, S.; Altun, E.; Yaman, H. Prevalence of metabolic syndrome in patients with mu-cosal lichen planus: A case-control study. Am. J. Clin. Dermatol., 2015, 16(5), 439-445.
[http://dx.doi.org/10.1007/s40257-015-0142-8] [PMID: 26179827]
[26]
Krishnamoorthy, B.; Gn, S. N S, M.; M B, S.; Garlapati, K. Lipid profile and metabolic syndrome status in patients with oral lichen planus, oral lichenoid reaction and healthy individuals attending a dental college in northern India - A descriptive study. J. Clin. Diagn. Res., 2014, 8(11), ZC92-ZC95.
[http://dx.doi.org/10.7860/JCDR/2014/9649.5188] [PMID: 25584327]
[27]
Aniyan, K.Y.; Guledgud, M.V.; Patil, K. Alterations of serum lipid profile patterns in oral lichen planus patients: A case-control study. Contemp. Clin. Dent., 2018, 9(5), S112-S121.
[http://dx.doi.org/10.4103/ccd.ccd_111_18] [PMID: 29962775]
[28]
López-Jornet, P.; Camacho-Alonso, F.; Rodríguez-Martínes, M.A. Alterations in serum lipid profile patterns in oral lichen planus: A cross-sectional study. Am. J. Clin. Dermatol., 2012, 13(6), 399-404.
[http://dx.doi.org/10.2165/11633600-000000000-00000] [PMID: 22924867]
[29]
Edgar, N.R.; Saleh, D.; Miller, R.A. Recurrent aphthous stomatitis: A review. J. Clin. Aesthet. Dermatol., 2017, 10(3), 26-36.
[PMID: 28360966]
[30]
Cimen, M.; Kaya, T.; Eskandari, G.; Tursen, U.; Ikizoglu, G.; Atik, U. Oxidant/antioxidant status in patients with recurrent aphthous stomatitis. Clinical and experimental dermatology. Clin. Exp. Dermatol., 2003, 28(6), 647-650.
[http://dx.doi.org/10.1046/j.1365-2230.2003.01415.x]
[31]
Karincaoglu, Y.; Batcioglu, K.; Erdem, T.; Esrefoglu, M.; Genc, M. The levels of plasma and salivary antioxidants in the patient with recurrent aphthous stomatitis. J. Oral Pathol. Med., 2005, 34(1), 7-12.
[http://dx.doi.org/10.1111/j.1600-0714.2004.00253.x] [PMID: 15610400]
[32]
Takci, Z.; Karadag, A.S.; Ertugrul, D.T.; Bilgili, S.G. Elevated insulin resistance in patients with recurrent aphthous stomatitis. Clin. Oral Investig., 2015, 19(6), 1193-1197.
[http://dx.doi.org/10.1007/s00784-014-1339-6] [PMID: 25346375]
[33]
Sereflican, M.; Sereflican, B.; Dagistan, E.; Goksugur, N.; Kizildag, B. Subclinical atherosclerosis in patients with recurrent aphthous stomatitis. Oral Dis., 2016, 22(6), 573-577.
[http://dx.doi.org/10.1111/odi.12497] [PMID: 27128209]
[34]
Akoglu, G.; Metin, A.; Kilinc, F.; Pektas, S.D.; Isikoglu, S.; Akbas, A.; Sener, S. Total serum oxidant/antioxidant status and arylesterase activity in recurrent aphthous stomatitis. Ann. Dermatol., 2013, 25(3), 273-277.
[http://dx.doi.org/10.5021/ad.2013.25.3.273] [PMID: 24003267]
[35]
Catapano, A.L.; Pirillo, A.; Bonacina, F.; Norata, G.D. HDL in innate and adaptive immunity. Cardiovasc. Res., 2014, 103(3), 372-383.
[http://dx.doi.org/10.1093/cvr/cvu150] [PMID: 24935428]
[36]
Yvan-Charvet, L.; Wang, N.; Tall, A.R. Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses. Arterioscler. Thromb. Vasc. Biol., 2010, 30(2), 139-143.
[http://dx.doi.org/10.1161/ATVBAHA.108.179283] [PMID: 19797709]
[37]
Yeter, H.H.; Erten, Y.; Sevmez, H.; Korucu, B.; Kalkanci, A.; Elbeg, S.; Altok, K.; Bali, M.; Yilmaz, H. Oral candida colonization as a risk factor for chronic inflammation and atherosclerosis in hemodialysis patients. Ther. Apher. Dial., 2019, 23(6), 542-549.
[http://dx.doi.org/10.1111/1744-9987.12803] [PMID: 30895718]
[38]
Kamali, M.; Sarvtin, M.T.; Parsanasab, H. Prevalence of candida infection in patients with type 2 diabetes mellitus in Sari, North of Iran. Biomed. Pharmacol. J., 2016, 9(2), 731-734.
[http://dx.doi.org/10.13005/bpj/996]
[39]
Kelishadi, R.; Mirmoghtadaee, P.; Qorbani, M.; Motlagh, M.E.; Heshmat, R.; Taslimi, M.; Mahmoudarabi, M.; Ardalan, G.; Larijani, B. Tooth brushing and cardiometabolic risk factors in adolescents: Is there an association? The CASPIAN-III study. Int. J. Prev. Med., 2013, 4(3), 271-278.
[PMID: 23626883]
[40]
Fujita, M.; Ueno, K.; Hata, A. Lower frequency of daily teeth brushing is related to high prevalence of cardiovascular risk factors. Exp. Biol. Med., 2009, 234(4), 387-394.
[http://dx.doi.org/10.3181/0809-RM-265] [PMID: 19176866]
[41]
Cinar, A.B.; Oktay, I.; Schou, L. Relationship between oral health, diabetes management and sleep apnea. Clin. Oral Investig., 2013, 17(3), 967-974.
[http://dx.doi.org/10.1007/s00784-012-0760-y] [PMID: 22648729]
[42]
Cinar, A.B.; Oktay, I.; Schou, L. Toothbrushing: A link between noncommunicable and communicable diseases? Oral Health Prev. Dent., 2015, 13(6), 515-522.
[PMID: 25884044]
[43]
Ylöstalo, P.V.; Ek, E.; Laitinen, J.; Knuuttila, M.L. Optimism and life satisfaction as determinants for dental and general health behavior-oral health habits linked to cardiovascular risk factors. J. Dent. Res., 2003, 82(3), 194-199.
[http://dx.doi.org/10.1177/154405910308200309] [PMID: 12598548]
[44]
Johansson, I.; Tidehag, P.; Lundberg, V.; Hallmans, G. Dental status, diet and cardiovascular risk factors in middle-aged people in Northern Sweden. Community Dent. Oral Epidemiol., 1994, 22(6), 431-436.
[http://dx.doi.org/10.1111/j.1600-0528.1994.tb00792.x] [PMID: 7882658]
[45]
Syrjälä, A.M.H.; Ylöstalo, P.; Hartikainen, S.; Sulkava, R.; Knuuttila, M. Number of teeth and selected cardiovascular risk factors among elderly people. Gerodontology, 2010, 27(3), 189-192.
[http://dx.doi.org/10.1111/j.1741-2358.2009.00328.x] [PMID: 19702670]
[46]
Brito-Zerón, P.; Baldini, C.; Bootsma, H.; Bowman, S.J.; Jonsson, R.; Mariette, X.; Sivils, K.; Theander, E.; Tzioufas, A.; Ramos-Casals, M. Sjogren syndrome. Nat. Rev. Dis. Primers, 2016, 2(1), 16047.
[http://dx.doi.org/10.1038/nrdp.2016.47] [PMID: 27383445]
[47]
Svenson, K.L.; Lithell, H.; Hällgren, R.; Selinus, I.; Vessby, B. Serum lipoprotein in active rheumatoid arthritis and other chronic in-flammatory arthritides. I. relativity to inflammatory activity. Arch. Intern. Med., 1987, 147(11), 1912-1916.
[http://dx.doi.org/10.1001/archinte.1987.00370110040005] [PMID: 3675091]
[48]
Lodde, B.M.; Sankar, V.; Kok, M.R.; Leakan, R.A.; Tak, P.P.; Pillemer, S.R. Serum lipid levels in sjogren’s syndrome. Rheumatology, 2006, 45(4), 481-484.
[http://dx.doi.org/10.1093/rheumatology/kei190] [PMID: 16303821]
[49]
Soukup, M.; Biesiada, I.; Henderson, A.; Idowu, B.; Rodeback, D.; Ridpath, L.; Bridges, E.G.; Nazar, A.M.; Bridges, K.G. Salivary uric acid as a noninvasive biomarker of metabolic syndrome. Diabetol. Metab. Syndr., 2012, 4(1), 14.
[http://dx.doi.org/10.1186/1758-5996-4-14] [PMID: 22515434]
[50]
DuBose, K.D.; McKune, A.J. The relation between salivary cortisol and the metabolic syndrome score in girls. J. Pediatr. Endocrinol. Metab., 2013, 26(9-10), 841-847.
[http://dx.doi.org/10.1515/jpem-2012-0415] [PMID: 23612697]
[51]
Konishi, S.; O’Connor, K.A. Salivary but not blood cortisol excretion is associated with metabolic biomarkers in healthy young women. Am. J. Hum. Biol., 2016, 28(4), 539-544.
[http://dx.doi.org/10.1002/ajhb.22827] [PMID: 26779782]
[52]
Lu, L.; Mackay, D.F.; Newby, D.E.; Pell, J.P. Association between salivary cotinine and cardiovascular biomarkers among nonsmokers and current smokers: Cross-sectional study of 10,081 participants. Eur. J. Vasc. Endovasc. Surg., 2014, 48(6), 703-710.
[http://dx.doi.org/10.1016/j.ejvs.2014.09.008] [PMID: 25454789]
[53]
S G, R.; Choudhry, A.A.; Gururaja, A.; Prabhu, K. Correlation of plasma lipid profile with salivary oxidative stress markers in type II diabetes mellitus patients. J. Clin. Diagn. Res., 2014, 8(6), CC08-CC10.
[PMID: 25120974]
[54]
Liu, Q.; Wang, Z.; Dong, X.; Wang, H.; Lan, J. Calcium, phosphorus and oxygen around implant at early osseointegration in hyper-lipidemic rats. J. Hard Tissue Biol., 2019, 28(1), 57-62.
[http://dx.doi.org/10.2485/jhtb.28.57]
[55]
Dong, X.; Wang, Z.; Wang, H.; Lan, J. The research of dishevelled-2 in dental implant osseointegration of hyperlipidemic rats. Int. J. Oral Maxillofac. Implants, 2018, 33(2), 351-356.
[http://dx.doi.org/10.11607/jomi.6015] [PMID: 29253039]
[56]
Liu, F.; Wang, Z.; Liu, F.; Xu, J.; Liu, Q.; Yin, K.; Lan, J. MicroRNA-29a-3p enhances dental implant osseointegration of hyperlipidem-ic rats via suppressing dishevelled 2 and frizzled 4. Cell Biosci., 2018, 8(1), 55.
[http://dx.doi.org/10.1186/s13578-018-0254-y] [PMID: 30386554]
[57]
Keuroghlian, A.; Barroso, A.D.V.; Kirikian, G.; Bezouglaia, O.; Tintut, Y.; Tetradis, S.; Moy, P.; Pirih, F.; Aghaloo, T. The effects of hyperlipidemia on implant osseointegration in the mouse femur. J. Oral Implantol., 2015, 41(2), e7-e11.
[http://dx.doi.org/10.1563/AAID-JOI-D-13-00105] [PMID: 24295508]
[58]
Tekin, M.B.; Toker, H. The effect of hyperlipidemia on bone graft regeneration of peri-implantal created defects in rabbits. Int. J. Implant Dent., 2019, 5(1), 18.
[http://dx.doi.org/10.1186/s40729-019-0170-x] [PMID: 31089911]
[59]
Ren, H.; Wang, Z.; Xu, J.; Chen, J.; Lan, J. The impact of frizzled-9 on dental implant osseointegration in hyperlipidemic rats. J. Hard Tissue Biol., 2020, 29(1), 37-44.
[http://dx.doi.org/10.2485/jhtb.29.37]
[60]
Ardila, C.M.; Olarte-Sossa, M.; Ariza-Garcés, A.A. Association between the presence of treponema denticola and reduced levels of antiatherogenic high density lipoprotein in periodontitis. Quintessence Int., 2015, 46(3), 207-215.
[PMID: 25328922]
[61]
Lönn, J.; Ljunggren, S.; Klarström-Engström, K.; Demirel, I.; Bengtsson, T.; Karlsson, H. Lipoprotein modifications by gingipains of Porphyromonas gingivalis. J. Periodontal Res., 2018, 53(3), 403-413.
[http://dx.doi.org/10.1111/jre.12527] [PMID: 29341140]
[62]
Ardila, C.M.; Guzmán, I.C. High levels of porphyromonas gingivalis-induced immunoglobulin G2 are associated with lower high-density lipoprotein levels in chronic periodontitis. J. Investig. Clin. Dent., 2016, 7(4), 368-375.
[http://dx.doi.org/10.1111/jicd.12169] [PMID: 26074399]
[63]
Kim, H.J.; Cha, G.S.; Kim, H.J.; Kwon, E.Y.; Lee, J.Y.; Choi, J.; Joo, J.Y. Porphyromonas gingivalis accelerates atherosclerosis through oxidation of high-density lipoprotein. J. Periodontal Implant Sci., 2018, 48(1), 60-68.
[http://dx.doi.org/10.5051/jpis.2018.48.1.60] [PMID: 29535891]
[64]
Kallio, K.A.; Buhlin, K.; Jauhiainen, M.; Keva, R.; Tuomainen, A.M.; Klinge, B.; Gustafsson, A.; Pussinen, P.J. Lipopolysaccharide associates with pro-atherogenic lipoproteins in periodontitis patients. Innate Immun., 2008, 14(4), 247-253.
[http://dx.doi.org/10.1177/1753425908095130] [PMID: 18669610]
[65]
Bozoglan, A.; Ertugrul, A.S. Taspınar, M.; Yuzbasioglu, B. Determining the relationship between atherosclerosis and periodontopatho-genic microorganisms in chronic periodontitis patients. Acta Odontol. Scand., 2017, 75(4), 233-242.
[http://dx.doi.org/10.1080/00016357.2017.1280739] [PMID: 28116969]
[66]
Pussinen, P.J.; Jauhiainen, M.; Vilkuna-Rautiainen, T.; Sundvall, J.; Vesanen, M.; Mattila, K.; Palosuo, T.; Alfthan, G.; Asikainen, S. Periodontitis decreases the antiatherogenic potency of high density lipoprotein. J. Lipid Res., 2004, 45(1), 139-147.
[http://dx.doi.org/10.1194/jlr.M300250-JLR200] [PMID: 13130123]
[67]
Leite, A.C.E.; Carneiro, V.M.; Guimarães, M.C. Effects of periodontal therapy on C-reactive protein and HDL in serum of subjects with periodontitis. Rev. Bras. Cir. Cardiovasc., 2014, 29(1), 69-77.
[http://dx.doi.org/10.5935/1678-9741.20140013] [PMID: 24896165]
[68]
Li, L.; Messas, E.; Batista, E.L., Jr; Levine, R.A.; Amar, S. Porphyromonas gingivalis infection accelerates the progression of athero-sclerosis in a heterozygous apolipoprotein E-deficient murine model. Circulation, 2002, 105(7), 861-867.
[http://dx.doi.org/10.1161/hc0702.104178] [PMID: 11854128]
[69]
Buhlin, K.; Gustafsson, A.; Pockley, A.G.; Frostegård, J.; Klinge, B. Risk factors for cardiovascular disease in patients with periodonti-tis. Eur. Heart J., 2003, 24(23), 2099-2107.
[http://dx.doi.org/10.1016/j.ehj.2003.09.016] [PMID: 14643270]
[70]
Fentoğlu, Ö.; Kırzıoğlu, F.Y.; Bulut, M.T.; Kumbul Doğuç, D.; Kulaç, E.; Önder, C.; Günhan, M. Evaluation of lipid peroxidation and oxidative DNA damage in patients with periodontitis and hyperlipidemia. J. Periodontol., 2015, 86(5), 682-688.
[http://dx.doi.org/10.1902/jop.2015.140561] [PMID: 25612631]
[71]
Awartani, F.; Atassi, F. Evaluation of periodontal status in subjects with hyperlipidemia. J. Contemp. Dent. Pract., 2010, 11(2), 33-40.
[http://dx.doi.org/10.5005/jcdp-11-2-33] [PMID: 20228985]
[72]
D’Isidoro, O.; Perrotti, V.; Hui, W.L.; Piattelli, A.; Iaculli, F.; Quaranta, A. The impact of non-surgical therapy of periodontal disease on surrogate markers for cardiovascular disease: A literature review. Am. J. Dent., 2019, 32(4), 191-200.
[PMID: 31436940]
[73]
Gomes-Filho, I.S.; Santos, P.N.P.; Cruz, S.S.; Figueiredo, A.C.M.G.; Trindade, S.C.; Ladeia, A.M.; Cerqueira, E.M.M.; Passos-Soares, J.S.; Coelho, J.M.F.; Hintz, A.M.; Barreto, M.L.; Fischer, R.G.; Loomer, P.M.; Scannapieco, F.A. Periodontitis and its higher levels of severity are associated with the triglyceride/high density lipoprotein cholesterol ratio. J. Periodontol., 2021, 92(11), 1509-1521.
[http://dx.doi.org/10.1002/JPER.21-0004] [PMID: 33689171]
[74]
Choi, Y.H.; Kosaka, T.; Ojima, M.; Sekine, S.; Kokubo, Y.; Watanabe, M.; Miyamoto, Y.; Ono, T.; Amano, A. Relationship between the burden of major periodontal bacteria and serum lipid profile: A cross-sectional Japanese study. BMC Oral Health, 2018, 18(1), 77.
[http://dx.doi.org/10.1186/s12903-018-0536-0] [PMID: 29728099]
[75]
Choukroun, J.; Khoury, G.; Khoury, F.; Russe, P.; Testori, T.; Komiyama, Y.; Sammartino, G.; Palacci, P.; Tunali, M.; Choukroun, E. Two neglected biologic risk factors in bone grafting and implantology: High low-density lipoprotein cholesterol and low serum vitamin D. J. Oral Implantol., 2014, 40(1), 110-114.
[http://dx.doi.org/10.1563/AAID-JOI-D-13-00062] [PMID: 24107195]
[76]
Papachristou, N.I.; Blair, H.C.; Kypreos, K.E.; Papachristou, D.J. High-Density Lipoprotein (HDL) metabolism and bone mass. J. Endocrinol., 2017, 233(2), R95-R107.
[http://dx.doi.org/10.1530/JOE-16-0657] [PMID: 28314771]
[77]
Pirih, F.; Lu, J.; Ye, F.; Bezouglaia, O.; Atti, E.; Ascenzi, M.G.; Tetradis, S.; Demer, L.; Aghaloo, T.; Tintut, Y. Adverse effects of hy-perlipidemia on bone regeneration and strength. J. Bone Miner. Res., 2012, 27(2), 309-318.
[http://dx.doi.org/10.1002/jbmr.541] [PMID: 21987408]
[78]
Saito, T.; Murakami, M.; Shimazaki, Y.; Oobayashi, K.; Matsumoto, S.; Koga, T. Association between alveolar bone loss and elevated serum C-reactive protein in Japanese men. J. Periodontol., 2003, 74(12), 1741-1746.
[http://dx.doi.org/10.1902/jop.2003.74.12.1741] [PMID: 14974814]
[79]
Jonarta, A.L.; Pudyani, P.S.; Sosroseno, W. Effect of high-density lipoprotein on lipopolysaccharide-induced alveolar bone resorption in rats. Oral Dis., 2002, 8(5), 261-267.
[http://dx.doi.org/10.1034/j.1601-0825.2002.01797.x] [PMID: 12363111]
[80]
The relationship between the mandibular bone quality assessed by digital panoramic radiography and serum biological parameters in patients planning dental implant surgery. Cumhur. Den. J., 2020, 23(1), 60-67.
[81]
Kumar, P.; Augustine, J.; Urs, A.B.; Arora, S.; Gupta, S.; Mohanty, V.R. Serum lipid profile in oral cancer and leukoplakia: Correlation with tobacco abuse and histological grading. J. Cancer Res. Ther., 2012, 8(3), 384-388.
[http://dx.doi.org/10.4103/0973-1482.103517] [PMID: 23174719]
[82]
Patel, P.S.; Shah, M.H.; Jha, F.P.; Raval, G.N.; Rawal, R.M.; Patel, M.M.; Patel, J.B.; Patel, D.D. Alterations in plasma lipid profile patterns in head and neck cancer and oral precancerous conditions. Indian J. Cancer, 2004, 41(1), 25-31.
[PMID: 15105576]
[83]
Poorey, V.K.; Thakur, P. Alteration of lipid profile in patients with head and neck malignancy. Indian J. Otolaryngol. Head Neck Surg., 2016, 68(2), 135-140.
[http://dx.doi.org/10.1007/s12070-015-0829-4] [PMID: 27340626]
[84]
Chawda, J.G.; Jain, S.S.; Patel, H.R.; Chaduvula, N.; Patel, K. The relationship between serum lipid levels and the risk of oral cancer. Indian J. Med. Paediatr. Oncol., 2011, 32(1), 34-37.
[http://dx.doi.org/10.4103/0971-5851.81888] [PMID: 21731214]
[85]
Mehta, R.; Gurudath, S.; Dayansoor, S.; Pai, A.; Ganapathy, K.S. Serum lipid profile in patients with oral cancer and oral precancerous conditions. Dent. Res. J., 2014, 11(3), 345-350.
[PMID: 25097644]
[86]
Subbulakshmi, A.C.; Mohan, N.; Thiruneervannan, R.; Naveen, S. Comparative evaluation of serum lipid profile in patients with oral submucous fibrosis and oral squamous cell carcinoma with that of control subjects: A case control study. J. Pharm. Bioallied Sci., 2017, 9(5), S191-S196.
[http://dx.doi.org/10.4103/jpbs.JPBS_142_17] [PMID: 29284962]
[87]
Lohe, V.K.; Degwekar, S.S.; Bhowate, R.R.; Kadu, R.P.; Dangore, S.B. Evaluation of correlation of serum lipid profile in patients with oral cancer and precancer and its association with tobacco abuse. J. Oral Pathol. Med., 2010, 39(2), 141-148.
[http://dx.doi.org/10.1111/j.1600-0714.2009.00828.x] [PMID: 20002982]
[88]
Garg, D.; Sunil, M.K.; Singh, P.P.; Singla, N.; Rani, S.R.; Kaur, B. Serum lipid profile in oral precancer and cancer: A diagnostic or prognostic marker? J. Int. Oral Health, 2014, 6(2), 33-39.
[PMID: 24876700]
[89]
Acharya, S.; Rai, P.; Hallikeri, K.; Anehosur, V.; Kale, J. Serum lipid profile in oral squamous cell carcinoma: Alterations and associa-tion with some clinicopathological parameters and tobacco use. Int. J. Oral Maxillofac. Implants, 2016, 45(6), 713-720.
[http://dx.doi.org/10.1016/j.ijom.2016.01.015] [PMID: 26899131]
[90]
Mahesh, N.; Rahamthullah, S.A.; Naidu, G.M.; Rajesh, A.; Babu, P.R.; Reddy, J.M. Alterations of plasma lipid profile patterns in oral leukoplakia. J. Int. Oral Health, 2014, 6(1), 78-84.
[PMID: 24653608]
[91]
Mehrotra, R.; Pandya, S.; Chaudhary, A.K.; Singh, H.P.; Jaiswal, R.K.; Singh, M.; Gupta, S.C.; Singh, M. Lipid profile in oral submu-cous fibrosis. Lipids Health Dis., 2009, 8(1), 29.
[http://dx.doi.org/10.1186/1476-511X-8-29] [PMID: 19630946]
[92]
Yashveer, J.K.; Pankaj, D. Alteration of serum lipid in oral sub mucous fibrosis in Central India. Indian J. Otolaryngol. Head Neck Surg., 2018, 70(3), 421-424.
[http://dx.doi.org/10.1007/s12070-018-1434-0] [PMID: 30211101]
[93]
Ganavi, B.S.; Patil, S.; Rao, R.S. Evaluation of serum lipids and lipoproteins as prognosticators in leukoplakia. J. Contemp. Dent. Pract., 2014, 15(3), 294-299.
[http://dx.doi.org/10.5005/jp-journals-10024-1531] [PMID: 25307809]

Rights & Permissions Print Cite
Article Metrics
29
2
World Chagas Disease
© 2024 Bentham Science Publishers | Privacy Policy